Nanjing Pharmaceutical Group Company Limited Class ASSE: 600713

"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on the Issuance Results of the 2nd Tranche of Medium-Term Notes for 2026

· Issued by Nanjing Pharmaceutical Group Company Limited Class A via Shanghai Stock Exchange
Announcement on the Issuance Results of the 2nd Tranche of Medium-Term Notes for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis